There is a photo that exemplifies the paradox of Robert F. Kennedy Jr.’s nomination as secretary of the Health and Human ...

After failing to gain traction in previous years, legislation to establish a Prescription Drug Affordability Board (PDAB) is ...

From Big Lots and Rite Aid to Sam Ash and Rue21 — retailers closed thousands of stores in 2024. Here are some of the most ...

The U.S. district judge in Cleveland, Ohio handling a galaxy of claims stemming from the prescription opioid epidemic on ...

Florida Governor DeSantis issued a statement in response to the report from the Grand Jury, tasked with investigating ...

We recently compiled a list of the 12 Best Growth Stocks Under $25 to Buy Now. In this article, we are going to take a look ...

STAT reporters discuss why a looming patent cliff could lead to more pharmaceutical deal-making and a new obesity startup.

The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug Pricing survey.

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

When the BIOSECURE Act hit a setback and missed the chance of becoming law in 2024, the deceleration of the draft legislation ...

Being laid off is bad enough. When companies mishandle the layoff process, it can make the situation even worse. Four ...

The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...